Form 4: Catalyst Pharmaceuticals Executive Reports Stock Transaction
Insider Transaction (Form 4)
Gregg Russo, Chief HR Officer of Catalyst Pharmaceuticals, Inc., reported multiple transactions in common stock on July 15, 2026.
Summary
- Disposition to the issuer: disposed of 476 Common Stock, par value $0.001 per share at $31.50 ($14,994) on July 15, 2026 (Direct).
- Disposition to the issuer: disposed of 15,000 Options to purchase common stock on July 15, 2026 (Direct).
- Disposition to the issuer: disposed of 6,957 Options to purchase common stock on July 15, 2026 (Direct).
- Disposition to the issuer: disposed of 20,349 Options to purchase common stock on July 15, 2026 (Direct).
- Disposition to the issuer: disposed of 20,531 Options to purchase common stock on July 15, 2026 (Direct).
- Disposition to the issuer: disposed of 2,752 Restricted Stock Units on July 15, 2026 (Direct).
- Disposition to the issuer: disposed of 6,197 Restricted Stock Units on July 15, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Gregg Russo — Officer (Chief HR Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Disposition to the issuer | Common Stock, par value $0.001 per share | 476 | $32 | $15.0K | 0 |
| 2026-07-15 | Disposition to the issuer | Options to purchase common stock | 15,000 | — | — | 0 |
| 2026-07-15 | Disposition to the issuer | Options to purchase common stock | 6,957 | — | — | 0 |
| 2026-07-15 | Disposition to the issuer | Options to purchase common stock | 20,349 | — | — | 0 |
| 2026-07-15 | Disposition to the issuer | Options to purchase common stock | 20,531 | — | — | 0 |
| 2026-07-15 | Disposition to the issuer | Restricted Stock Units | 2,752 | — | — | 0 |
| 2026-07-15 | Disposition to the issuer | Restricted Stock Units | 6,197 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Disposition to the issuer (476 shares) |
| 2026-07-15 | Disposition to the issuer (15,000 shares) |
| 2026-07-15 | Disposition to the issuer (6,957 shares) |
| 2026-07-15 | Disposition to the issuer (20,349 shares) |
| 2026-07-15 | Disposition to the issuer (20,531 shares) |
| 2026-07-15 | Disposition to the issuer (2,752 shares) |
| 2026-07-15 | Disposition to the issuer (6,197 shares) |
Keywords
insider transaction, Form 4, CPRX, CATALYST PHARMACEUTICALS, INC., neutral, Gregg Russo
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.